Is Novavax Stock a good buy in 2023, according to Wall Street analysts?
The consensus among 2 Wall Street analysts covering (NASDAQ: NVAX) stock is to Buy NVAX stock.
Out of 2 analysts, 0 (0%) are recommending NVAX as a Strong Buy, 1 (50%) are recommending NVAX as a Buy, 1 (50%) are recommending NVAX as a Hold, 0 (0%) are recommending NVAX as a Sell, and 0 (0%) are recommending NVAX as a Strong Sell.
According to 2 Wall Street analysts that have issued a 1 year NVAX price target, the average NVAX price target is $60.00, with the highest NVAX stock price forecast at $110.00 and the lowest NVAX stock price forecast at $10.00.
On average, Wall Street analysts predict that Novavax's share price could reach $60.00 by Mar 1, 2024. The average Novavax stock price prediction forecasts a potential upside of 765.8% from the current NVAX share price of $6.93.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.